MATINAS BIOPHARMA HOLDINGS, INC. Public Float
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Public Float of $4.50 million as of 2025-06-30, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-31
- 2025-06-30: Entity Public Float $4.50M.
- 2024-06-30: Entity Public Float $38.70M.
- 2023-06-30: Entity Public Float $75.90M.
- 2022-06-30: Entity Public Float $164.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $4.50M 10-K · filed 2026-03-31 |
| 2024-06-30 | $38.70M 10-K · filed 2025-04-15 |
| 2023-06-30 | $75.90M 10-K · filed 2024-03-27 |
| 2022-06-30 | $164.80M 10-K · filed 2023-03-15 |
| 2021-06-30 | $160.00M 10-K/A · filed 2022-03-11 |
| 2020-06-30 | $141.90M 10-K · filed 2021-03-29 |
| 2019-06-28 | $111.80M 10-K · filed 2020-03-09 |
| 2018-06-30 | $33.70M 10-K · filed 2019-04-01 |
| 2017-06-30 | $123.10M 10-K · filed 2018-03-16 |
| 2016-06-30 | $27.70M 10-K · filed 2017-03-31 |
| 2015-06-30 | $34.50M 10-K · filed 2016-03-30 |
| 2014-07-21 | $23.20M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |